Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCI | P41743 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 12/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 10/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.44 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.44 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 4/20 | 0.44 |
| ▸ | HTT | P42858 | 3/20 | 0.44 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 7/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.43 |
| ▸ | RAB9A | P51151 | 5/20 | 0.43 |
| ▸ | NPC1 | O15118 | 4/20 | 0.43 |
| ▸ | GLA | P06280 | 3/20 | 0.43 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
| ▸ | GFER | P55789 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetamide SCHEMBL7680194 | 0.83 | MAPT (0.41) | PRKCIMAPTKDM4ERAD52MEN1 | |
| Trifluoroacetic Acid SCHEMBL4108467 | 0.83 | MAPT (0.41) | PRKCIMAPTKDM4ERAD52MEN1 | |
| SCHEMBL111984 | 0.83 | DYRK1A (0.48) | PRKCIMAPTKDM4ERAD52MEN1 | |
| Tert-Butyl Formate SCHEMBL28826667 | 0.81 | TDP1 (0.37) | PRKCIMAPTKDM4ERAD52MEN1 | |
| SCHEMBL8421908 | 0.81 | DYRK1A (0.47) | PRKCIMAPTKDM4ERAD52MEN1 | |
| Fluoride SCHEMBL31379737 | 0.81 | DYRK1A (0.47) | PRKCIMAPTKDM4ERAD52MEN1 | |
| Hydrochloric Acid SCHEMBL2493619 | 0.81 | DYRK1A (0.47) | PRKCIMAPTKDM4ERAD52MEN1 | |
| Hydrochloric Acid SCHEMBL10929282 | 0.81 | DYRK1A (0.47) | PRKCIMAPTKDM4ERAD52MEN1 | |
| SCHEMBL12871076 | 0.74 | — | — | |
| SCHEMBL2611832 | 0.74 | KMT2A (0.43) | MAPTKDM4EKMT2AHTTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110713868-A | Post etch residue cleaning solution capable of removing titanium nitride | 巴斯夫欧洲公司 | 2020-01-21 | — | — | CN | claimed |
| CN-101686979-A | The urea modulators that the heteroaryl of fatty acid amide hydrolase replaces | JANSSEN PHARMACEUTICA NV | 2010-03-31 | — | — | CN | claimed |
| EP-2164493-A2 | HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE | Janssen Pharmaceutica, N.V. (BE) | 2010-03-24 | — | — | EP | claimed |
| US-20090062294-A1 | HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE | JANSSEN PHARMACEUTICA NV (BE) | 2009-03-05 | — | — | US | claimed |
| WO-2008153752-A2 | HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-12-18 | — | — | WO | claimed |
| EP-0851282-B1 | Processing of a light-sensitive silver halide photographic material | AGFA GEVAERT (BE) | 2003-04-16 | — | — | EP | claimed |
| US-5912108-A | FORMING IMAGES BY EXPOSURE TO LIGHT ON SUPPORTS | AGFA-GEVAERT, N.V. (BE) | 1999-06-15 | — | — | US | claimed |
| EP-0851282-A1 | Processing of a light-sensitive silver halide photographic material | AGFA-GEVAERT N.V. (BE) | 1998-07-01 | — | — | EP | claimed |
| US-20250197399-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | TENVIE THERAPEUTICS, INC. | 2025-06-19 | — | — | US | disclosed |
| EP-4499626-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | Nico Therapeutics, Inc. (US) | 2025-02-05 | — | — | EP | disclosed |
| CN-119233972-A | Compounds, compositions, and methods | 尼科治疗有限公司 | 2024-12-31 | — | — | CN | disclosed |
| WO-2023192390-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | DENALI THERAPEUTICS INC. (US) | 2023-10-05 | — | — | WO | disclosed |
| US-11414410-B2 | Inhibitors of protein kinases | ALEXION PHARMACEUTICALS, INC. (US) | 2022-08-16 | — | — | US | disclosed |
| US-11299480-B2 | 2-arylsulfonamido-N-arylacetamide derivatized STAT3 inhibitors | UNIVERSITY OF HAWAII (US) | 2022-04-12 | — | — | US | disclosed |
| WO-2006062982-A2 | UREA INHIBITORS OF MAP KINASES | LOCUS PHARMACEUTICALS, INC. (US) | 2006-06-15 | — | — | WO | disclosed |
| EP-1519235-A2 | Linked dihydrazone-based charge transport compounds | Samsung Electronics Co., Ltd. (KR) | 2005-03-30 | — | — | EP | disclosed |
| US-20050058916-A1 | Linked dihydrazone-based charge transport compounds | S-PRINTING SOLUTION CO., LTD. (KR) | 2005-03-17 | — | — | US | disclosed |
| EP-0851282-B1 | Processing of a light-sensitive silver halide photographic material | AGFA GEVAERT (BE) | 2003-04-16 | — | — | EP | disclosed |
| US-5912108-A | FORMING IMAGES BY EXPOSURE TO LIGHT ON SUPPORTS | AGFA-GEVAERT, N.V. (BE) | 1999-06-15 | — | — | US | disclosed |
| EP-0851282-A1 | Processing of a light-sensitive silver halide photographic material | AGFA-GEVAERT N.V. (BE) | 1998-07-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11299480-B2 | 2-arylsulfonamido-N-arylacetamide derivatized STAT3 inhibitors | STAT3, JAK2, STAT5A | PRKCI 397/4885MAPT 3464/4885KDM4E 2607/4885 |
| US-20090062294-A1 | HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE | FAAH, FAAH2, GPR119 | PRKCI 1870/4885MAPT 1808/4885KDM4E 950/4885 |
| US-11414410-B2 | Inhibitors of protein kinases | MAP3K1, MAP3K20, MAP3K2 | PRKCI 77/4885MAPT 2325/4885KDM4E 1016/4885 |
| US-20250197399-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | NLRP3, NLRP1, NOD1 | PRKCI 2951/4885MAPT 3816/4885KDM4E 3822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.